Genotype-Phenotype Comparison of German <i>MLH1</i> and <i>MSH2</i> Mutation Carriers Clinically Affected With Lynch Syndrome: A Report by the German HNPCC Consortium

Abstract

The proportion of rectal cancers and shorter time span to metachronous cancers indicates the need for a defined treatment strategy for primary rectal cancers in hereditary nonpolyposis colorectal cancer patients. Male MLH1 mutation carriers require earlier colonoscopy beginning at age 20 years. We propose regular gastric surveillance starting at age 35 years, regardless of the familial occurrence of this cancer. The association of prostate cancer with MSH2 mutations should be taken into consideration both for clinical and genetic counseling practice.